HT
SRNE

HAP Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

HAP Trading’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,600
Closed -$55K – 1802
2022
Q4 		$55K Sell
10,600
-500
-5% -$663 0.01% 717
2022
Q3 		$48K Buy
+11,100
New +$25.2K ﹤0.01% 1000
2022
Q1 		– Sell
-41,400
Closed -$114K – 2957
2021
Q4 		$114K Buy
41,400
+10,000
+32% +$62.1K ﹤0.01% 1199
2021
Q3 		$66K Buy
31,400
+5,900
+23% +$50K ﹤0.01% 1413
2021
Q2 		$46K Sell
25,500
-11,900
-32% -$94.8K ﹤0.01% 1507
2021
Q1 		$91K Sell
37,400
-16,300
-30% -$172K ﹤0.01% 986
2020
Q4 		$148K Sell
53,700
-18,100
-25% -$145K ﹤0.01% 1043
2020
Q3 		$98K Buy
71,800
+30,800
+75% +$282K ﹤0.01% 799
2020
Q2 		$32K Buy
+41,000
New +$157K ﹤0.01% 1180
2015
Q4 		– Sell
-20,000
Closed -$142K – 1163
2015
Q3 		$142K Buy
+20,000
New +$319K 0.01% 559

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

HAP Trading's SRNE Position: Q4 2021 in Review

HAP Trading sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2021, closing a stake of 61,523 shares — an estimated $382K sold.

HAP Trading first reported a position in SRNE in Q1 2021 and held it in 3 quarters. The position peaked at $469K in Q3 2021. 234 funds tracked by Wall St. Rank hold SRNE as of Q4 2021.

  • HAP Trading reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 61,523 Sorrento Therapeutics, Inc. shares in Q4 2021, an estimated $382K.
  • HAP Trading first reported a position in Sorrento Therapeutics, Inc. in Q1 2021 and held it in 3 quarters.
  • HAP Trading's Sorrento Therapeutics, Inc. position peaked at $469K in Q3 2021.
  • 234 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.